Comparative Effectiveness of mRNA and Viral Vector COVID-19 Vaccines in Multicentric Populations

Abstract

The global rollout of COVID-19 vaccines has relied heavily on two major platforms: messenger RNA (mRNA) vaccines and viral vector vaccines. While both demonstrate efficacy in preventing severe disease and mortality, differences in real-world effectiveness across diverse populations remain underexplored.